Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Deferred Tax (2019 - 2023)

Silo Pharma (SILO) has disclosed Long-Term Deferred Tax for 5 consecutive years, with $2.5 million as the latest value for Q4 2023.

  • Quarterly Long-Term Deferred Tax rose 63.74% to $2.5 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2023, up 63.74% year-over-year, with the annual reading at $2.5 million for FY2023, 63.74% up from the prior year.
  • Long-Term Deferred Tax hit $2.5 million in Q4 2023 for Silo Pharma, up from $1.6 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $2.5 million in Q4 2023 to a low of $609530.0 in Q4 2021.
  • Historically, Long-Term Deferred Tax has averaged $1.3 million across 5 years, with a median of $992271.0 in 2020.
  • Biggest five-year swings in Long-Term Deferred Tax: plummeted 38.57% in 2021 and later soared 154.36% in 2022.
  • Year by year, Long-Term Deferred Tax stood at $614751.0 in 2019, then surged by 61.41% to $992271.0 in 2020, then tumbled by 38.57% to $609530.0 in 2021, then soared by 154.36% to $1.6 million in 2022, then skyrocketed by 63.74% to $2.5 million in 2023.
  • Business Quant data shows Long-Term Deferred Tax for SILO at $2.5 million in Q4 2023, $1.6 million in Q4 2022, and $609530.0 in Q4 2021.